Fig. 4
From: Simultaneous targeted and discovery-driven clinical proteotyping using hybrid-PRM/DIA
Identified protein groups by DIA or by DIA in hybrid-PRM/DIA in thirty melanoma patient samples. A The graph displays the number of identified protein groups per measurement for thirty melanoma patient samples. The samples were measured as technical replicates using DIA and hybrid-PRM/DIA. In B, the protein group measurements of DIA and hybrid-PRM/DIA are presented in a heatmap, clustered by hierarchical clustering (blue: DIA, red: hybrid-PRM/DIA)